K123067 is an FDA 510(k) clearance for the PROGRESS GUIDE WIRE FAMILY, PILOT GUIDE WIRE FAMILY. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.
Submitted by Abbott Vascular, Inc. (Temecula, US). The FDA issued a Cleared decision on January 29, 2013 after a review of 120 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Abbott Vascular, Inc. devices
NCT01435031
Completed
Interventional
Industry-sponsored
EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
| Condition studied |
Coronary Artery Disease (CAD); Chronic Total Occlusion (CTO) |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
David E. Kandzari, MD |
| Sponsor |
Abbott Medical Devices
(industry)
|
Started 2011-09-01
→
Primary completion 2014-02-01
→
Completed 2017-12-01
Primary outcome
Number of Participants With Stent-related: Major Adverse Cardiac Events (MACE) (Per ITT Set)
Secondary outcome
Minimum Lumen Diameter (MLD): Pre-procedure
View full study on ClinicalTrials.gov